final analysis of the phase 3 tourmaline-mm1: ixazomib lenalidomide-dex vs placebo-rd in rrmm
Published 3 years ago • 507 plays • Length 7:11
Download video MP4
Download video MP3
Similar videos
-
4:48
overview of the final analysis of the phase iii tourmaline-mm1 trial
-
6:33
the phase 3 tourmaline-mm2 trial
-
7:11
updates from icaria-mm, a phase 3 study of isa pomalidomide & low-dose dex (pd) versus pd in rrmm
-
4:19
tourmaline-mm3 and 4: ixazomib as maintenance therapy in myeloma patients
-
8:12
effectiveness and safety of ixazomib-based therapy in rrmm outside of a clinical trial: uvea ixa
-
11:13
isatuximab, carfilzomib, lenalidomide, and dex (isa-krd) in pts with high-risk newly diagnosed mm
-
5:28
daratumumab with ixazomib and dex in pts with one prior lenalidomide-based regimen: the daria study
-
4:19
final analysis of uvea-ixa study of ixazomib in r/r myeloma
-
4:06
myeloma patient tiffany williams shares her myeloma journey
-
6:45
hoya vivinex™ gemetric™ trifocal iol case study
-
9:57
teclistamab, a bcma × cd3 bispecific antibody, in pts with rrmm: updated phase 1 results
-
7:15
endeavour, aspire and tourmaline-mm1 trial results for multiple myeloma
-
10:45
myeloma patient questions: myeloma causes, side effects, light chain levels, darzalex, ivig, & more
-
2:21
the phase 3 tourmaline-mm2 trial
-
7:25
updated phase 1 results of teclistamab, a bcma × cd3 bispecific antibody, in rrmm
-
2:51
phase ii trial of the combination of ixazomib, lenalidomide, and dexamethasone in high-risk smou...
-
4:20
what were the results of the determination trial presented at asco and eha?
-
7:19
tourmaline-mm2: clinically meaningful results in multiple myeloma trial
-
9:57
measurable residual disease evaluation during ixazomib maintenance in ndmm: tourmaline-mm3 and -mm4
-
2:54
tourmaline-mm4: oral ixazomib maintenance for myeloma
-
2:49:09
approaches to achieve the best possible outcomes in myeloma
Clip.africa.com - Privacy-policy